434 results on '"Hack, A. C."'
Search Results
2. Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
3. Predicting mammographic density with linear ultrasound transducers
4. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
5. Gutartige Veränderungen der Mamma und Veränderungen biologisch unsicheren Verhaltens
6. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
7. Anatomie mit klinischen Bezügen: Teil 2 – Mamma
8. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
9. CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs
10. RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
11. Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
12. Complementary and alternative medicine (CAM) in women with endometriosis
13. Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany
14. Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
15. Vitamine und Spurenelemente
16. Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
17. RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
18. Hereditäre Karzinome in der Gynäkologie
19. Die CAPTOR-BC-Studie.
20. Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
21. The contributions of breast density and common genetic variation to breast cancer risk.
22. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study.
23. RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
24. Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
25. Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2
26. Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization
27. Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer
28. Complementary medicine in radiation oncology: German health care professionals’ current qualifications and therapeutic methods
29. External-Beam-Accelerated Partial-Breast Irradiation Reduces Organ-at-Risk Doses Compared to Whole-Breast Irradiation after Breast-Conserving Surgery
30. HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
31. Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 years
32. Breast cancer patients’ satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service
33. Low-Risk Women with Suspicious Microcalcifications in Mammography—Can an Additional Breast MRI Reduce the Biopsy Rate?
34. Erratum: Mammakarzinom beim Mann
35. Mammakarzinom beim Mann
36. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT)
37. The modern landscape of sport-related concussion research: key achievements and future directions
38. Clarifications concerning the commentary “Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed”
39. Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable
40. Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis
41. Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
42. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network
43. Systematik der integrativen Medizin: Übersicht und Stellenwert in der Onkologie
44. External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis
45. Mammakarzinom beim Mann.
46. Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics
47. RETRACTED ARTICLE: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
48. Diagnosis, Therapy and Follow-up of Cervical Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
49. Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable.
50. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.